ICPA Health Products Introduces Coolora Spray - A Rapid Relief Solution For Oral & Throat Discomfort

▴ ICPA Health Products
The product will be available at leading pharmacies nationwide, as well as through popular e-pharmacies, ensuring easy accessibility for all individuals seeking effective relief for oral and throat discomfort.

Mumbai, Feb 2024: India’s leading Pharma Company in the oral healthcare segment - ICPA Health Products Ltd (ICPA) has introduced its newest oral healthcare solution – Coolora Spray. Specifically designed as a mouth spray, the product effectively addresses inflammatory and painful conditions in the mouth and throat, including post-tonsillectomy pain control, pharyngitis, laryngitis, oral mucositis, mouth ulcers and burning sensations. Coolora Spray proves highly effective in reaching the tonsils and posterior pharyngeal wall, providing effective relief within just two minutes of application. Packed in a convenient 25 ml High-Density Polyethylene (HDPE) bottle equipped with a metered dose valve pump, a single spray delivers 250 micrograms of Benzydamine Hydrochloride.

ICPA has expanded its product range with the introduction of Coolora spray, alongside the existing Coolora gargle. A spray form of delivery brings unique benefits, especially in easing post-tonsillectomy surgical pain for patients who struggle with gargling after the surgery. Additionally, for children who have difficulty gargling, the spray would be more suitable because it eliminates the chances of gargle swallowing. This move reflects ICPA’s commitment to making healthcare more accessible for everyone.

The active ingredient in Coolora Spray, Benzydamine Hydrochloride 0.15 per cent, belongs to the category of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). Operating in the throat and mouth, the spray effectively alleviates pain and inflammation by inhibiting the synthesis of pro-inflammatory cytokines such as tumour necrosis factor-alpha (TNF-α) and interleukin-1β (IL-1β).

Coolora Spray is suitable for both adults and children, with varying recommended dosages. For adults, it is advised to spray 4 to 8 puffs onto the affected area every 1½ to 3 hours. Children aged 6 to 12 years should administer four puffs, while those under 6 years old should apply one puff for every 4 kilograms of body weight, up to a maximum of four puffs, every 1½ to 3 hours.

The product will be available at leading pharmacies nationwide, as well as through popular e-pharmacies, ensuring easy accessibility for all individuals seeking effective relief for oral and throat discomfort.

Company name: ICPA Health Products Ltd.

Product name: Coolora Spray

Qty.: 25 ml

MRP: Rs.190/-

About ICPA Health Products (ICPA): -

ICPA Health Products Ltd. is the leading Indian manufacturer in the oral healthcare segment with well-known, trusted products like Thermoseal and Hexidine. Headquartered in Mumbai, the 50 year old company has an international presence in South-East Asia, Middle-East, UK, Australia and French West Africa. In addition to dental products, ICPA also specializes in herbal and cosmetic products all of which are manufactured at its state-of-the-art, facility certified by the EU, WHO GMP and ISO in Gujarat. ICPA enjoys the franchise of around 70 per cent of India’s dental surgeons along with a significant number of ENTs and cancer specialists in the subcontinent.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Medicolegal Risks in TelemedicineJune 24, 2025
Digital Mental Health Clinics in Tier-2 CitiesJune 24, 2025
AssisTech Foundation Hosts Inclusive Job Festival for Persons with DisabilitiesJune 23, 2025
Travel with Ease: Why Congestion Patches Are the Smart Traveler’s Secret WeaponJune 23, 2025
Paper-Tech Platform Paper Arizona Hits ₹100 Cr Annual Revenue Milestone, Eyes IPO Listing in 2026June 23, 2025
Eat Better to enhance its Quick Commerce Operations with UnicommerceJune 23, 2025
Stahl Unveils Blacksmith Signature Cast Iron Tawas: A Classic Essential with a Modern Update for Timeless Indian KitchensJune 23, 2025
Lilly’s once-weekly insulin efsitora alfa demonstrated A1C reduction and a safety profile consistent with daily insulin in multiple Phase 3 trialsJune 23, 2025
Finding strength in struggle for gender equality and human rightsJune 23, 2025
CTS Speciality Hospital Brings Robotic Knee Surgery Ushering in a New Era of Joint CareJune 23, 2025
Air Quality & Cardiovascular Morbidity: The Missing LinkJune 23, 2025
Menstrual Product Tax Relief & Health AccessJune 23, 2025
Sports Medicine Goes Virtual via WearablesJune 23, 2025
The Silent Guardian: How Smart Pill Dispensers Bring Peace to Indian FamiliesJune 23, 2025
Low-Cost AI Diagnostics for Retinal DiseaseJune 23, 2025
Yoga Beyond Fitness: Olive Hospital Spreads Awareness on Its Preventive Health BenefitsJune 21, 2025
Medanta- The Medicity Underscores Commitment to Holistic Well-Being Through Large-Scale International Yoga Day CelebrationsJune 21, 2025
The Rise of Digital Symptom Checkers in IndiaJune 21, 2025
3-D Printed Prosthetics for Indian AmputeesJune 21, 2025
The Silent Drain: Why NAFLD is Hurting Middle Aged India's Health and WalletJune 21, 2025